Literature DB >> 9338488

Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other beta-lactams.

H E Villar1, F Danel, D M Livermore.   

Abstract

An imipenem-resistant mutant of Proteus mirabilis lacked a 26 kDa outer membrane protein (OMP). It has previously been postulated that this protein is a porin, but the present mutant, which was cross-resistant to mecillinam but not to other beta-lactams, proved as permeable to carbapenems as its parent. A mecillinam-selected mutant had similar cross-resistance yet retained the 26 kDa OMP, confirming that this protein was not important to resistance. In contrast, cefoxitin-selected mutants retained the 26 kDa protein but had diminished expression of major 41 and 44 kDa OMPs and showed reduced uptake of carbapenems, although this promoted resistance only when a carbapenemase was also present. We conclude that the imipenem-selected mutant owed its resistance to some factor other than porin loss, probably to a lesion in penicillin-binding protein 2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9338488     DOI: 10.1093/jac/40.3.365

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.

Authors:  Hervé Dupont; Olivier Gaillot; Anne-Sophie Goetgheluck; Claire Plassart; Jean-Philippe Emond; Marion Lecuru; Nicolas Gaillard; Sarah Derdouri; Baptiste Lemaire; Marion Girard de Courtilles; Vincent Cattoir; Hedi Mammeri
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

2.  Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate.

Authors:  Delphine Girlich; Rémy A Bonnin; Pierre Bogaerts; Morgane De Laveleye; Daniel T Huang; Laurent Dortet; Philippe Glaser; Youri Glupczynski; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

3.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 4.  Carbapenems: past, present, and future.

Authors:  Krisztina M Papp-Wallace; Andrea Endimiani; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

5.  Chromosome-encoded class D beta-lactamase OXA-23 in Proteus mirabilis.

Authors:  R Bonnet; H Marchandin; C Chanal; D Sirot; R Labia; C De Champs; E Jumas-Bilak; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Cross-Sectional Survey of Antibiotic Resistance in Extended Spectrum β-Lactamase-Producing Enterobacteriaceae Isolated from Pigs in Greece.

Authors:  Nikolaos Tsekouras; Zoi Athanasakopoulou; Celia Diezel; Polychronis Kostoulas; Sascha D Braun; Marina Sofia; Stefan Monecke; Ralf Ehricht; Dimitris C Chatzopoulos; Dominik Gary; Domenique Krähmer; Vassiliki Spyrou; Georgios Christodoulopoulos; Charalambos Billinis; Vasileios G Papatsiros
Journal:  Animals (Basel)       Date:  2022-06-16       Impact factor: 3.231

7.  Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection.

Authors:  Christopher Lucasti; Liviu Vasile; Dorel Sandesc; Donatas Venskutonis; Patrick McLeroth; Mallika Lala; Matthew L Rizk; Michelle L Brown; Maria C Losada; Alison Pedley; Nicholas A Kartsonis; Amanda Paschke
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

8.  Rapid detection of blaKPC carbapenemase genes by real-time PCR.

Authors:  Musa Hindiyeh; Gill Smollen; Zehava Grossman; Daniela Ram; Yehudit Davidson; Fernando Mileguir; Marina Vax; Debbie Ben David; Ilana Tal; Galia Rahav; Ari Shamiss; Ella Mendelson; Nathan Keller
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

9.  Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC beta-lactamase in P. mirabilis.

Authors:  R Tibbetts; J G Frye; J Marschall; D Warren; W Dunne
Journal:  J Clin Microbiol       Date:  2008-07-16       Impact factor: 5.948

10.  Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing.

Authors:  Fred C Tenover; Rajinder K Kalsi; Portia P Williams; Roberta B Carey; Sheila Stocker; David Lonsway; J Kamile Rasheed; James W Biddle; John E McGowan; Bruce Hanna
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.